Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0X4CO
|
|||
Former ID |
DNC009678
|
|||
Drug Name |
CHIR-98023
|
|||
Synonyms |
CT-98014
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C20H16Cl2N8O2
|
|||
Canonical SMILES |
C1=CC(=C(C=C1Cl)Cl)C2=NC(=NC=C2C3=NC=CN3)NCCNC4=NC=C(C=C4)[N+](=O)[O-]
|
|||
InChI |
1S/C20H16Cl2N8O2/c21-12-1-3-14(16(22)9-12)18-15(19-24-6-7-25-19)11-28-20(29-18)26-8-5-23-17-4-2-13(10-27-17)30(31)32/h1-4,6-7,9-11H,5,8H2,(H,23,27)(H,24,25)(H,26,28,29)
|
|||
InChIKey |
GUMBZKISKUIHJB-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 252916-76-0
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Fragment and knowledge-based design of selective GSK-3beta inhibitors using virtual screening models. Eur J Med Chem. 2009 Jun;44(6):2361-71. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.